GlobeNewswire 2023-12-11 Orchard Therapeutics Receives Swissmedic Approval for Libmeldy in Early-onset MLD
GlobeNewswire 2023-12-11 BioXcel Therapeutics Strengthens Clinical Development Leadership to Advance Late-Stage Programs
GlobeNewswire 2023-12-08 FibroGen/Astellas’ EVRENZO (roxadustat) Making In-Roads in European Market as In-Class Challenger, A...
GlobeNewswire 2023-12-06 Wave Life Sciences Announces Initiation of Dosing in RestorAATion Clinical Program Evaluating First-...
GlobeNewswire 2023-11-30 Levicept Appoints Eliot Forster as CEO
GlobeNewswire 2023-11-27 Anaptys Expands Immune Cell Modulator Pipeline with Exclusive License to BDCA2 Modulator Antibody Po...
GlobeNewswire 2023-11-27 Meet the Companies Named to Computerworld’s 2024 Best Places to Work in IT List
GlobeNewswire 2023-11-27 Enhanced Potential of Myricx’s NMT Inhibitor Payloads with Dual Senolytic and Cytotoxic Modes of Act...
GlobeNewswire 2023-11-27 Ocuphire Pharma Announces Appointment of Joseph Schachle, M.B.A., as Chief Operating Officer
GlobeNewswire 2023-11-24 Sosei Heptares to Regain Full Ownership of GSK4381406*, a Clinic-ready, First-in-Class Oral GPR35 Ag...
GlobeNewswire 2023-11-22 Algernon Pharmaceuticals Announces LOI for the Acquisition of its Chronic Cough Research Program by ...
GlobeNewswire 2023-11-21 SCYX STOCK NEWS: Investors with Significant Losses in Scynexis, Inc. Should Contact Robbins LLP for ...
GlobeNewswire 2023-11-20 Moa Technology hires for further growth with expansion of its leadership team – announcing appointme...
GlobeNewswire 2023-11-17 Ivy Brain Tumor Center Announces Promising Data for Niraparib in Phase 0/2 Glioblastoma Clinical Tri...
GlobeNewswire 2023-11-15 T-Therapeutics raises £48 million Series A for development of next generation TCR therapeutics to tr...
GlobeNewswire 2023-11-15 OMass Therapeutics expands leadership team with the appointment of Melissa Faris as Chief Business O...
GlobeNewswire 2023-11-13 SCYNEXIS Reports Third Quarter 2023 Financial Results and Provides Corporate Update
GlobeNewswire 2023-11-13 SCYX Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Scynexi...
GlobeNewswire 2023-11-13 Spero Therapeutics Announces Third Quarter 2023 Operating Results and Provides a Business Update
GlobeNewswire 2023-11-13 LIXTE Biotechnology Provides Update on Clinical Progress and Expanding Collaborations
Newsfile Corp 2023-11-09 PurMinds Appoints Leading Drug Designer, Dr. Alan Kozikowski, to Chief Scientific Officer and Appoin...
GlobeNewswire 2023-11-09 Wave Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update
GlobeNewswire 2023-11-08 23andMe Reports Second Quarter Fiscal 2024 Financial Results
GlobeNewswire 2023-11-08 Spherix Global Insights Amplifies the Lupus Patient Voice, Highlighting the Lengthy and Challenging ...
GlobeNewswire 2023-11-08 Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against SCYNEXIS, Inc. (SC...